基底细胞痣综合征
PTCH1型
医学
牙源性的
痣样基底细胞癌综合征
皮肤病科
基底细胞癌
基底细胞
遗传咨询
维莫德吉
病理
基因检测
癌
多学科方法
角化囊肿
痣
脂肪增多症
外科
基础(医学)
癌症
成釉细胞瘤
作者
Antonio Pereira-González,Guillermo Moreno-Casas,Carmen Ruiz‐Iglesias,José Javier Márquez-Rojas,Basilo Narváez-Moreno,Isabel Rodríguez‐Nevado,Antonio Javier Chaves Álvarez,Francisco Peral Rubio,Marta Torres-Díaz,Enrique Galán Gómez
摘要
Background Gorlin syndrome (GS), also known as naevoid basal cell carcinoma syndrome, is a rare autosomal dominant disorder characterized by a predisposition to multiple neoplasms and developmental anomalies. It is mainly associated with pathogenic variants in genes involved in the Sonic Hedgehog signalling pathway, particularly PTCH1 and SUFU. Early diagnosis is important because of the high recurrence of lesions and the substantial morbidity associated with repeated treatments. Objectives To analyse the frequency and therapeutic management of the main dermatological manifestations in a cohort of patients with GS, and to propose a practical multidisciplinary management algorithm. Methods We conducted a retrospective observational study of 10 patients with a clinical diagnosis of GS who underwent genetic testing using next-generation sequencing and multiplex ligation-dependent probe amplification. Diagnosis was established according to the 2011 international consensus criteria. Results Ten patients were included, with a mean age at diagnosis of 35 years and a male-to-female ratio of 7 : 3. The most frequent manifestations were basal cell carcinomas (BCCs; 90%), palmoplantar pits (90%) and odontogenic keratocysts (80%). In total, 608 BCCs were identified. Surgical excision was the most frequently used treatment (58%), followed by cryotherapy, topical imiquimod and vismodegib. Vismodegib was used in two patients with extensive disease, achieving complete clinical clearance of BCCs, although recurrence occurred after treatment discontinuation. Genetic testing identified pathogenic PTCH1 variants in five patients; no pathogenic SUFU variants were detected. Conclusions GS is a complex genodermatosis associated with considerable dermatological and extracutaneous morbidity. Dermatologists play a central role in early recognition, treatment and long-term surveillance. A multidisciplinary approach and structured follow-up algorithms may help optimize care and reduce the cumulative burden of disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI